Description
Zanubrutinib, sold under the brand name Brukinsa, is a medication for the treatment of adults with mantle cell lymphoma (MCL) who have received at least one prior therapy. It was approved for medical use in the United States in November 2019. Zanubrutinib is classified as a Bruton’s tyrosine kinase (BTK) inhibitor.
Get Access to BRUKINSA (zanubrutinib) capsules In India
Medvitaz Pharma is equipped to facilitate the distribution of BRUKINSA (zanubrutinib) capsules(prescription medications) worldwide and throughout India upon completion of necessary legal procedures, if applicable.
To inquire about the price of either the branded medication “BRUKINSA (zanubrutinib) capsules” or the generic version “zanubrutinib” for personal use under patient-specific treatment in various cities including Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura, Sikkim, and others in India, please fill out the request form. Upon receiving your request and assessing the delivery process, we will provide you with an estimated price for the medication within 24 hours.
For any inquiries or assistance, please reach out to our Patient Support Team. We are available to assist you from Monday to Friday, between 9:00 and 19:00 IST. You can contact us via email at [email protected], toll-free at +91 8750295029, or through WhatsApp at +91-8750295029.
We can help facilitate the supply of BRUKINSA (zanubrutinib) capsules through legal channels.